BDRL — Blonder Tongue Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00TechnologyHighly SpeculativeMicro Cap
- $1.37m
- $7.43m
- $18.12m
Annual cashflow statement for Blonder Tongue Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.34 | -0.742 | -7.47 | 0.084 | -2.92 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.673 | -5.36 | 1.58 | 0.076 | 2.03 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.836 | -0.828 | 2.33 | -1.67 | -0.615 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Cash from Operating Activities | 0.587 | -6.54 | -3.21 | -1.17 | -1.38 |
| Capital Expenditures | -0.101 | -0.316 | -0.191 | -0.086 | -0.055 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | 9.79 | 0 | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.101 | 9.47 | -0.191 | -0.086 | -0.055 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.095 | -2.92 | 2.9 | 1.46 | 1.24 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.391 | 0.013 | -0.503 | 0.205 | -0.195 |